195 related articles for article (PubMed ID: 30066842)
1. Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
Chen X; Xu Z; Zhu Z; Chen A; Fu G; Wang Y; Pan H; Jin B
Int J Oncol; 2018 Oct; 53(4):1703-1712. PubMed ID: 30066842
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells.
Wang X; Wu G; Cao G; Yang L; Xu H; Huang J; Hou J
Mol Med Rep; 2015 Sep; 12(3):4620-4625. PubMed ID: 26126921
[TBL] [Abstract][Full Text] [Related]
3. Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
Fang Z; Jiang C; Feng Y; Chen R; Lin X; Zhang Z; Han L; Chen X; Li H; Guo Y; Jiang W
Biochim Biophys Acta; 2016 Sep; 1863(9):2245-54. PubMed ID: 27217331
[TBL] [Abstract][Full Text] [Related]
4. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
Sun Y; Gu X; Zhang E; Park MA; Pereira AM; Wang S; Morrison T; Li C; Blenis J; Gerbaudo VH; Henske EP; Yu JJ
Cell Death Dis; 2014 May; 5(5):e1231. PubMed ID: 24832603
[TBL] [Abstract][Full Text] [Related]
5. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
6. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Ho JN; Byun SS; Lee SE; Youn JI; Lee S
Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
[TBL] [Abstract][Full Text] [Related]
7. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
8. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
[TBL] [Abstract][Full Text] [Related]
9. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide, a glucose-6-phosphate dehydrogenase non-competitive mixed inhibitor, modifies redox balance and lipid accumulation in 3T3-L1 cells.
Torres-Ramírez N; Baiza-Gutman LA; García-Macedo R; Ortega-Camarillo C; Contreras-Ramos A; Medina-Navarro R; Cruz M; Ibáñez-Hernández MÁ; Díaz-Flores M
Life Sci; 2013 Dec; 93(25-26):975-85. PubMed ID: 24184296
[TBL] [Abstract][Full Text] [Related]
11. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
13. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
14. Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.
Li Y; Zheng F; Zhang Y; Lin Z; Yang J; Han X; Feng Y; Pei X; Li F; Liu Q; Yan L; Li T; Zhang Y; Li D; Fu Z; Wang C; Sun Q; Li C
FEBS J; 2023 Feb; 290(3):763-779. PubMed ID: 36048131
[TBL] [Abstract][Full Text] [Related]
15. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
[TBL] [Abstract][Full Text] [Related]
16. G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma.
Wang X; Liu H; Zhang X; Li X; Gu H; Zhang H; Fan R
Tumour Biol; 2016 Jan; 37(1):781-9. PubMed ID: 26250461
[TBL] [Abstract][Full Text] [Related]
17. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
18. Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.
Ju HQ; Lu YX; Wu QN; Liu J; Zeng ZL; Mo HY; Chen Y; Tian T; Wang Y; Kang TB; Xie D; Zeng MS; Huang P; Xu RH
Oncogene; 2017 Nov; 36(45):6282-6292. PubMed ID: 28692052
[TBL] [Abstract][Full Text] [Related]
19. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS-mediated inactivation of the PI3K/Akt pathway.
Ahn KI; Choi EO; Kwon DH; HwangBo H; Kim MY; Kim HJ; Ji SY; Hong SH; Jeong JW; Park C; Kim ND; Kim WJ; Choi YH
Biosci Trends; 2017 Nov; 11(5):565-573. PubMed ID: 29070760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]